Post-Ingestion Biotransformation and Functional-Food Bioefficacy: From Food Matrix to Host Response
Molecules · 19.11.2026 · 31 (22) · 4212
DOI: 10.3390/molecules31224212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 19.11.2026. Verfasst von Tania María Guzmán-Armenteros und 2 weiteren Autor:innen. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Functional-food efficacy cannot be inferred from bioactive-compound content alone. Matrix structure, digestion, microbial and host metabolism, and interindividual variability influence which metabolites reach biological targets. This critical review examined post-ingestion biotransformation as a determinant of functional-food efficacy, integrating evidence identified through PubMed, Scopus, Web of Science, and CENTRAL across four representative pathways—ellagitannin–urolithin, daidzein–equol, dietary fibre–short-chain fatty acids, and glucoraphanin–sulforaphane—with the choline/L-carnitine–TMA/TMAO pathway as a counterexample. Across the pathways reviewed, precursor concentration alone was insufficient to predict functional exposure; conversion efficiency, metabolite identity, food matrix, microbial capacity, exposure kinetics, and host phenotype were recurrent determinants. Direct metabolite delivery improved exposure consistency in pharmacokinetic comparisons, but comparative clinical efficacy remained dependent on pathway, population, formulation, and endpoint. The review’s contribution is to compare precursor-rich, preformed-metabolite, enzyme-assisted, and hybrid strategies within a common sequence linking precursor delivery, conversion, internal exposure, variability, and host response, and to distinguish them according to the type of supporting evidence. Current evidence is limited by heterogeneous designs, variable metabolite quantification, selected populations, and few direct precursor-versus-metabolite comparisons. The strongest technological support applies where conversion can be controlled experimentally, particularly enzyme-assisted glucoraphanin-to-sulforaphane conversion. Evidence for hybrid approaches is pathway-specific: inulin–propionate ester has been tested in human interventions, whereas precursor–metabolite hybrids for urolithins and equol remain conceptual. Post-ingestion biotransformation should therefore be integrated within established bioaccessibility–bioavailability–bioefficacy concepts rather than treated as a new functional-food category.
Zitieren
APA
Guzmán-Armenteros, T. M., Echeverría, A., & Ramos-Guerrero, L. (2026). Post-Ingestion Biotransformation and Functional-Food Bioefficacy: From Food Matrix to Host Response. Molecules, 31(22), 4212. https://doi.org/10.3390/molecules31224212
Vancouver
Guzmán-Armenteros TM, Echeverría A, Ramos-Guerrero L. Post-Ingestion Biotransformation and Functional-Food Bioefficacy: From Food Matrix to Host Response. Molecules. 2026;31(22):4212. doi:10.3390/molecules31224212
BibTeX
@article{GuzmnArmenteros2026,
author = {Guzmán-Armenteros, Tania María and Echeverría, Armando and Ramos-Guerrero, Luis},
title = {Post-Ingestion Biotransformation and Functional-Food Bioefficacy: From Food Matrix to Host Response},
journal = {Molecules},
year = {2026},
volume = {31},
number = {22},
pages = {4212},
doi = {10.3390/molecules31224212}
}
EUVIMED